ViaDerma (ViaDerma) Price-to-Tangible-Book : 0.00 (As of Jun. 22, 2024)

View and export this data going back to 2008. Start your Free Trial

What is ViaDerma Price-to-Tangible-Book?

As of today (2024-06-22), ViaDerma's share price is $0.0055. ViaDerma's Tangible Book per Share of Jun. 2012 for the quarter that ended in Jun. 2012 was $255.59. Hence, ViaDerma's Price to Tangible Book Ratio of today is 0.00.

The historical rank and industry rank for ViaDerma's Price-to-Tangible-Book or its related term are showing as below:

VDRM's Price-to-Tangible-Book is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 2.31
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, ViaDerma's share price is $0.0055. ViaDerma's Book Value per Sharefor the quarter that ended in Jun. 2012 was $255.59. Hence, ViaDerma's P/B Ratio of today is 0.00.

ViaDerma Price-to-Tangible-Book Historical Data

The historical data trend for ViaDerma's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ViaDerma Price-to-Tangible-Book Chart

ViaDerma Annual Data

Trend

Dec07

Dec08

Dec09

Dec10

Dec11

Price-to-Tangible-Book

0.10

0.04

0.01

ViaDerma Quarterly Data
	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12
Price-to-Tangible-Book	Get a 7-Day Free Trial															0.03	0.03	-	0.02	0.03

Competitive Comparison of ViaDerma's Price-to-Tangible-Book

For the Drug Manufacturers - Specialty & Generic subindustry, ViaDerma's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ViaDerma's Price-to-Tangible-Book Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, ViaDerma's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where ViaDerma's Price-to-Tangible-Book falls into.

ViaDerma Price-to-Tangible-Book Calculation

ViaDerma's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Jun. 2012 )
	=	0.0055	/	255.593
	=	0.00

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

ViaDerma Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of ViaDerma's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

ViaDerma (ViaDerma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ViaDerma Inc (OTCPK:VDRM) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

N/A

Address

4640 Admiralty Way, Suite 500, Marina Del Rey, CA, USA, 90292

Website

https://www.viaderma.com

ViaDerma Inc is a specialty pharmaceutical company focused to bring new products to market through research and development. It is engaged in the business of manufacturing and sales of pharmaceuticals, and specifically topical antibiotics and pain management in the United States of America. Its sells under the brand name Vitastem. The Company also has products in development in the fields; anti-aging skin care, pain management, hair-loss, and toenail fungus.